Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (18)
  • Antithrombotics (394)
    • Drug-Induced Thrombosis (37)
    • Prevention (38)
    • Reversal (17)
    • Treatment (354)
      • Apixaban (Eliquis) (95)
      • Aspirin (187)
      • Clopidogrel (Plavix) (123)
      • Dabigatran (Pradaxa) (117)
      • Edoxaban (Savaysa) (31)
      • Low Molecular Weight Heparins (72)
      • Other (54)
      • Prasugrel (Effient) (54)
      • Rivaroxaban (Xarelto) (118)
      • Ticagrelor (Brilinta) (35)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (38)
      • Warfarin - Treatment (171)
  • Arrhythmias (187)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (105)
  • Dyslipidemia (283)
  • Endocarditis (21)
  • Heart Disease (88)
  • Heart Failure (205)
  • Hypertension (330)
  • Hypotension (22)
  • Ischemic Heart Disease/Acute Coronary Syndromes (369)
  • Myocardial Infarction (45)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (3)
  • Resources (964)
  • Stroke (181)
106 - 120 of 354 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Weigh Antithrombotic Risks and Benefits for Atrial Fib Patients With CAD November 2016
Article: Help Patients Understand Pros and Cons of ASA After a GI Bleed November 2016
PL Voices: Aspirin to Reduce Cardiovascular Risk After a GI Bleed November 2016
Chart: Canadian Atrial Fibrillation Guidelines: Focus on Pharmacotherapy November 2016
Guideline: Management of Atrial Fibrillation: Complete Guidelines Listing (2016) November 2016
Article: Look for Atrial Fib Patients Who May Need Anticoagulation October 2016
PL Voices: Anticoagulation in Atrial Fibrillation October 2016
Article: Recommend Praxbind to Reverse Life-threatening Bleeding in Patients on Pradaxa July 2016
Article: Recommend Using Actual Weight to Dose Enoxaparin in Obese Patients July 2016
Technician Tutorial: Injectable Anticoagulants July 2016
PL Voices: Praxbind (idarucizumab) to Reverse Bleeding with Pradaxa (dabigatran) July 2016
PL Voices: Use of Low-Molecular-Weight Heparin in Obesity and Renal Impairment July 2016
Article: Expect Some Stent Patients to Use Two Antiplatelet Meds Less Than 12 Months June 2016
PL Voices: Duration of Dual Antiplatelet Therapy June 2016
Guideline: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease June 2016
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved